Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Hold
3,147
0.51% 20
2026
Q1
$1.11M Buy
3,147
+23
+0.7% +$8.2K 0.59% 19
2025
Q4
$1.02M Sell
3,124
-137
-4% -$43.5K 0.55% 20
2025
Q3
$920K Buy
3,261
+98
+3% +$28.4K 0.49% 26
2025
Q2
$883K Buy
3,163
+396
+14% +$112K 0.51% 22
2025
Q1
$862K Sell
2,767
-86
-3% -$25.4K 0.54% 28
2024
Q4
$744K Buy
+2,853
New +$846K 0.46% 32

Other funds holding AMGN

Sylvest Advisors's AMGN Position: Q2 2026 in Review

Sylvest Advisors held its Amgen (AMGN) position steady in Q2 2026 at 3,147 shares worth $1.14M. The position accounts for 0.51% of the portfolio, ranked #20.

Sylvest Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,293 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sylvest Advisors held 3,147 shares of Amgen worth $1.14M as of Q2 2026.
  • Sylvest Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.51% of Sylvest Advisors's portfolio in Q2 2026, its #20 holding.
  • Sylvest Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,293 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sylvest Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.